Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Carcinoma (RCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07494435
What this trial is testing

Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC

Who this might be right for
Hepato Cellular Carcinoma (HCC)Renal Cell Cancer
Zhejiang Haichang Biotech Co., Ltd. 230
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Early research (Phase 1)Study completedNCT04374877
What this trial is testing

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorClear Cell Renal Cell CarcinomaHepatocellular Carcinoma+1 more
Coherus Oncology, Inc. 145
Early research (Phase 1)Ended earlyNCT06546553
What this trial is testing

Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

Who this might be right for
NeoplasmsNon-small-cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+3 more
Pfizer 10
Early research (Phase 1)Active Not RecruitingNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 13
Testing effectiveness (Phase 2)Ended earlyNCT04203901
What this trial is testing

Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma
CoImmune 16
Testing effectiveness (Phase 2)UnknownNCT01219751
What this trial is testing

Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Asan Medical Center 35
Early research (Phase 1)UnknownNCT05311618
What this trial is testing

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 71
Testing effectiveness (Phase 2)Study completedNCT03685448
What this trial is testing

ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)

Who this might be right for
Renal Cell CarcinomaPapillary Renal Cell Carcinoma Type 1Papillary Renal Cell Carcinoma Type 2+3 more
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 35
Testing effectiveness (Phase 2)Ended earlyNCT04904302
What this trial is testing

Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00853372
What this trial is testing

AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With Sunitinib

Who this might be right for
Advanced Renal Cell Carcinoma
Amgen 85
Early research (Phase 1)Study completedNCT02947165
What this trial is testing

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

Who this might be right for
Breast CancerLung CancerHepatocellular Cancer+3 more
Novartis Pharmaceuticals 120
Early research (Phase 1)Ended earlyNCT06158958
What this trial is testing

Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors

Who this might be right for
Solid Tumors
AbbVie 27
Not applicableEnded earlyNCT04147143
What this trial is testing

CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study

Who this might be right for
Advanced Renal Cell Carcinoma (All Subtypes)Metastatic Renal Cell Carcinoma (All Subtypes)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT06245915
What this trial is testing

AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Advanced/Metastatic Clear Cell Renal Cell CarcinomaRecurrence
Arsenal Biosciences, Inc. 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03284385
What this trial is testing

Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Clear Cell Renal Cell CarcinomaLocally Advanced Malignant Solid Neoplasm+4 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT03339219
What this trial is testing

Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma
Takeda 35
Early research (Phase 1)Looking for participantsNCT06910657
What this trial is testing

IDOV-Immune for Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerMelanoma+13 more
ViroMissile, Inc. 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07602101
What this trial is testing

Neoadjuvant PD-L1 Inhibitor Plus Anlotinib for Kidney Preservation in Complex Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
RenJi Hospital 33
Not applicableStudy completedNCT03229083
What this trial is testing

Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma
University of Rochester 21
Next Page